IN the four decades since the first cases of what would come to be known as AIDS were documented, scientists have made huge strides in HIV treatment, transforming what was once a death sentence to a manageable condition.
What we still don't have is a vaccine that would train human immune systems to ward off the infection before it ever takes root.
Here's the state of play on some of these efforts, which experts see as the "holy grail" in the fight to eliminate a virus that 38 million people live with globally.
- Why do we need a vaccine? -
More people than ever now have access to medications called antiretroviral therapy or ART, which when taken as prescribed, keeps down the amount of virus in their body.
This keeps them healthy and unable to transmit HIV to their partners.
Beyond ART, people at high risk for infection can now get pre-exposure prophylaxis, or PrEP, a pill taken every day that reduces the risk of infection by 99 percent.
"But access to medication is not organized in every part of the world," Hanneke Schuitemaker, global head of viral vaccine discovery at Johnson & Johnson's Janssen Vaccines, told AFP.
Even within wealthy countries, wide socio-economic and racial disparities exist in accessing these medicines, and vaccines have historically been the most effective tools to eradicate infectious diseases.
J&J is currently carrying out two human efficacy trials for its HIV vaccine candidate, and initial results from one of them may come as early as "the end of this year," Schuitemaker said.
- Why is it so challenging? -
Vaccines against Covid-19 were developed in record time and have shown remarkable levels of safety and efficacy, helping drive down caseloads in the countries fortunate enough to have wide access.
Many of these shots were developed using technologies that were previously being tried out on HIV so why haven't we had breakthroughs yet?
"The human immune system doesn't self cure HIV, whereas what was very clear was the human immune system was quite capable of self curing Covid-19," Larry Corey, principal investigator of HVTN, a global organization funding HIV vaccine development, told AFP.
Covid vaccines work by eliciting antibodies that bind to the virus' spike protein and stop it from infecting human cells.
HIV also has spike-shaped proteins on its surface, which are the target of HIV vaccine development.
But while Covid has tens of well known variants circulating worldwide, HIV has hundreds or thousands of variants inside each infected person, William Schief, an immunologist leading development of an mRNA HIV vaccine at Scripps Research Institute told AFP.
Because it's a "retrovirus" it quickly incorporates itself into its host's DNA. An effective vaccine will need to stop the infection dead in its tracks, not just reduce the amount of virus and leave the remainder to stay with the person forever.
- Where do things stand now? -
Efforts to develop a vaccine have been going on for decades but have so far all ended in failure.
Last year, a study called Uhambo that was taking place in South Africa and involved the only vaccine candidate ever shown to provide some protection against the virus frustratingly ended in failure.
J&J's vaccine candidate is currently being trialed in 2,600 women in sub-Saharan Africa in the Imbokodo trial, which is expected to report results in the coming months.
It's also being tested in around 3,800 men who have sex with men and transgender individuals across the US, South America and Europe in the Mosaico trial.
The J&J vaccine uses similar adenovirus technology to its Covid-19 vaccine, in other words a genetically modified cold virus delivers genetic cargo carrying instructions for the host to develop "mosaic immunogens" -- molecules capable of inducing an immune response to a wide variety of HIV strains.
This is followed up by directly injecting synthetic proteins in later doses.
Another promising approach is to try to generate "broadly neutralizing antibodies" (bnAbs) which bind to areas of the HIV virus that are common across its many variants.
The International AIDS Vaccine Initiative and Scripps Research recently announced results from an early stage trial showing their vaccine candidate stimulated the production of rare immune cells needed as a first step in the process of inducing bnAbs.
They are partnering with Moderna in the next stage of developing an mRNA vaccine.
Their strategy, explained Schief, is to use a sequence of shots to try to gradually educate antibody producing B-cells. They also hope to train up another kind of white cell, known as T-cells, to kill any cells that still get infected despite the antibodies.
Efficacy trials are still a long way off, but he's hopeful the mRNA technology, which turn the body's cells into vaccine factories and has proven its worth against Covid-19, can make the difference.
ETX Studio
Tue Jun 08 2021
HIV also has spike-shaped proteins on its surface, which are the target of HIV vaccine development. ETXStudiopic
Korea Selatan pindahkan 97 rakyatnya dari Lubnan
Kementerian Luar Korea Selatan maklumkan, kesemua mereka tiba di Korea Selatan pada petang Sabtu.
Pelarian tiba di Syria selepas serangan Israel ke atas Lubnan - UNHCR
Lebih 200,000 warga Syria dan Lubnan telah tiba di Syria dari Lubnan sejak serangan Israel bermula 23 September lalu.
[LAPOR LANGSUNG] Lebih 2,000 terkorban di Lubnan akibat serangan Israel
Jumlah mangsa yang maut itu termasuk 261 wanita dan 127 kanak-kanak.
Lebih 2,000 terkorban di Lubnan akibat serangan Israel
Laporan Al Jazeera menyebut, jumlah mangsa yang maut itu termasuk 261 wanita dan 127 kanak-kanak.
AWANI Pagi: Pendayaupayaan Pembangunan Sosio Ekonomi Bagi Memacu Wilayah Persekutuan
Ikuti temu bual bersama Menteri di Jabatan Perdana Menteri (Wilayah Persekutuan), Dr Zaliha Mustafa di #AWANIPagi jam 7.30 pagi di saluran 501 Astro AWANI.
Pentagon, Jabatan Negara AS beri amaran jenayah perang Israel
Pegawai-pegawai tersebut telah memberi amaran peningkatan jumlah kematian di Gaza mungkin melanggar undang-undang antarabangsa.
200,000 pelarian tiba di Syria selepas serangan Israel ke atas Lubnan - UNHCR
Lebih 200,000 warga Syria dan Lubnan telah tiba di Syria dari Lubnan sejak serangan Israel bermula pada 23 Sept.
Belanjawan 2025: Kesalinghubungan internet di sekolah, kampus jadi keutamaan - Fahmi
Kementerian Komunikasi akan memberikan keutamaan dengan meneruskan usaha untuk meningkatkan dan memantapkan lagi prasarana kesalinghubungan melibatkan isu Internet, dalam Belanjawan 2025 yang akan dibentangkan pada 18 Okt ini.
Setahun solidariti, sokongan global untuk Palestin di tengah-tengah genosid berterusan Israel
Ribuan manusia di seluruh dunia turun ke jalanan untuk menyuarakan sokongan kepada Palestin dan menuntut keadilan.
Indonesia kecewakan China, raih kejuaraan badminton berpasukan campuran remaja dunia
Indonesia menewaskan China untuk muncul Juara Badminton Berpasukan Campuran Remaja Dunia dengan kemenangan 110-103 (mata terkumpul).
Parlimen: Analisis data projek rintis ubat rawat HIV menunjukkan penurunan
Analisis awal projek perintis penggunaan ubat Pre-Exposure Prophylaxis (PrEP) yang digunakan untuk pencegahan HIV menunjukkan penurunan drastik.
Teknologi rawatan HIV kini bantu pesakit hidup normal - MAC
Teknologi rawatan HIV ketika ini telah menyaksikan kemajuan yang sangat baik dalam usaha membantuk penghidap HIV atau PLHIV hidup dengan sihat.
14 kanak-kanak di India dijangkiti HIV, Hepatitis selepas transfusi darah
Seramai 14 kanak-kanak dijangkiti HIV serta Hepatitis B dan C selepas melakukan pemindahan darah di sebuah hospital kerajaan.
Rawatan PrEP perlu dilihat dengan lebih meluas
Apa yang penting adalah bidang perubatan bertujuan merawat sesiapa sahaja dan bukannya menghukum.
Jangkitan baharu HIV menurun 70 peratus dalam tempoh 20 tahun - KKM
Rawatan ubat antiretroviral kepada orang yang hidup dengan HIV telah dipertingkatkan kepada 66 peratus pada tahun lepas.
Hapuskan ketidaksamaan untuk lenyapkan AIDS -Dr Adeeba
Stigma dan diskriminasi menjadi penghalang yang tidak diperlukan kepada perkhidmatan rawatan, pencegahan dan penjagaan HIV.
Sebanyak 90 peratus penghidap HIV/AIDS adalah lelaki
Sebanyak 90 peratus penghidap HIV/AIDS di negara ini adalah terdiri daripada golongan lelaki, kata Ketua Sektor HIV/AIDS dan Hepatitis C Kementerian Kesihatan Dr Anita Suleiman.
MAF komited tangani peningkatan kes HIV, AIDS - Dr Adeeba
Sebelum ini MAF alami kekangan untuk melaksanakan program berkaitan berikutan banyak pihak yang terlibat membantu memerangi COVID-19.
LGBT bertentangan dengan budaya Malaysia, undang-undang negara - Idris
Di bawah Seksyen 377 Kanun Keseksaan, adalah menjadi satu kesalahan bagi mana-mana orang yang melakukan persetubuhan yang bertentangan dengan aturan fitrah.
Penemu virus HIV, Luc Montagnier meninggal dunia
Berita pemergiannya itu disahkan pegawai kerajaan Perancis yang menyatakan Montagnier meninggal dunia pada Selasa.